The Comparative Safety of Abciximab Versus Eptifibatide in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

OBJECTIVES: We sought to evaluate the patterns of use and outcomes associated with eptifibatide and abciximab administration among dialysis patients who underwent PCI. BACKGROUND: Contraindicated medications are frequently administered to dialysis patients undergoing PCI often resulting in adverse o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Interv Cardiol
Päätekijät: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Hanzel, George, Khandelwal, Akshay, Cannon, Louis A., Lalonde, Thomas A., Gurm, Hitinder S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850214/
https://ncbi.nlm.nih.gov/pubmed/28543770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joic.12388
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia